TrialInvestigational new drugs2012
A phase II trial of Erlotinib in combination with gemcitabine and cisplatin in advanced pancreatic cancer.
In Gyu Hwang et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
9 papers cite it
this paperpooled itcites it